ANAPLASTIC MIXED OLIGOASTROCYTOMA

Clinical trials for ANAPLASTIC MIXED OLIGOASTROCYTOMA explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC MIXED OLIGOASTROCYTOMA trials appear

Sign up with your email to follow new studies for ANAPLASTIC MIXED OLIGOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

Experimental drug ruxolitinib joins standard therapy in brain cancer battle

Disease control Completed

This early-phase study tested whether adding the experimental drug ruxolitinib to standard radiation and chemotherapy (temozolomide) is safe for people with newly diagnosed high-grade gliomas or glioblastoma. Ruxolitinib targets proteins that help cancer cells grow. The study enr…

Matched conditions: ANAPLASTIC MIXED OLIGOASTROCYTOMA

Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

ANAPLASTIC MIXED OLIGOASTROCYTOMA

Get alerted when new ANAPLASTIC MIXED OLIGOASTROCYTOMA trials appear

Experimental drug ruxolitinib joins standard therapy in brain cancer battle